Overslaan en naar de inhoud gaan

 Alle verbonden artikelen

Continuous Renal Replacement Therapy for Acute Renal Failure in Patients with Cancer: A Well-Tolerated Adjunct Treatment.

Auteurs : Fischler R, Meert AP, Sculier JP, Berghmans T
Jaar : 2016
Journal : Front Med (Lausanne)
Volume : 3
Pagina's : 33

Monitoring metabolic response using FDG PET-CT during targeted therapy for metastatic colorectal cancer.

Auteurs : Woff E, Hendlisz A, Garcia C, Deleporte A, Delaunoit T, Maréchal R, Holbrechts S, Van den Eynde M, Demolin G, Vierasu I, Lhommel R, Gauthier N, Guiot T, Ameye L, Flamen P
Jaar : 2016
Journal : Eur J Nucl Med Mol Imaging
Volume : 43(10)
Pagina's : 1792-801

Dose-Seeking Phase I Trials for Currently Approved Molecular-Targeted Therapies in the USA: The Dose-Limiting Toxicity Definition Issue

Auteurs : Kotecki N, Awada A, Bonneterre J, Hebbar M, Adenis A, Cortot AB, Cousin C, Clisant S, Duhamel A, Penel N
Jaar : 2016
Journal : Pharmaceutical Medicine
Volume : 30(3)
Pagina's : 143-7

Cabozantinib for metastatic breast carcinoma: results of a phase II placebo-controlled randomized discontinuation study.

Auteurs : Tolaney SM, Nechushtan H, Ron IG, Schöffski P, Awada A, Yasenchak CA, Laird AD, OKeeffe B, Shapiro GI, Winer EP
Jaar : 2016
Journal : Breast Cancer Res Treat
Volume : 160
Pagina's : 305-312

Reply to the letter to the editor 'The ESMO Magnitude of Clinical Benefit Scaling Tool: from theory to practice' by Hartmann and the letter 'Comment on ESMO Magnitude of Clinical Benefit Scale' by Muhonen et al.

Auteurs : Cherny NI, Sullivan R, Dafni U, Kerst JM, Sobrero A, Zielinski C, de Vries EG, Piccart-Gebhart M
Jaar : 2016
Journal : Ann Oncol
Volume : 27
Pagina's : 203-5

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.

Auteurs : Maertens JA, Raad II, Marr KA, Patterson TF, Kontoyiannis DP, Cornely OA, Bow EJ, Rahav G, Neofytos D, Aoun M, Baddley JW, Giladi M, Heinz WJ, Herbrecht R, Hope W, Karthaus M, Lee DG, Lortholary O, Morrison VA, Oren I, Selleslag D, Shoham S, Thompson GR 3rd, Lee M, Maher RM, Schmitt-Hoffmann AH, Zeiher B, Ullmann AJ
Jaar : 2016
Journal : Lancet
Volume : 387(10020)
Pagina's : 760-9

Management of febrile neutropaenia: ESMO Clinical Practice Guidelines.

Auteurs : Klastersky J, de Naurois J, Rolston K, Rapoport B, Maschmeyer G, Aapro M, Herrstedt J
Jaar : 2016
Journal : Ann Oncol
Volume : 27
Pagina's : v111-v118

No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized Trial.

Auteurs : Demeestere I, Brice P, Peccatori FA, Kentos A, Dupuis J, Zachee P, Casasnovas O, Van Den Neste E, Dechene J, De Maertelaer V, Bron D, Englert Y
Jaar : 2016
Journal : J Clin Oncol
Volume : 34(22)
Pagina's : 2568-74

Tumour-educated circulating monocytes are powerful candidate biomarkers for diagnosis and disease follow-up of colorectal cancer.

Auteurs : Hamm A, Prenen H, Van Delm W, Di Matteo M, Wenes M, Delamarre E, Schmidt T, Weitz J, Sarmiento R, Dezi A, Gasparini G, Rothé F, Schmitz R, Dhoore A, Iserentant H, Hendlisz A, Mazzone M
Jaar : 2016
Journal : Gut
Volume : 65(6)
Pagina's : 990-1000

Imaging Diagnostic and Therapeutic Targets: Human Epidermal Growth Factor Receptor 2.

Auteurs : Gebhart G, Flamen P, de Vries EG, Jhaveri K, Wimana Z
Jaar : 2016
Journal : J Nucl Med
Volume : 57 Suppl 1
Pagina's : 81S-8S

Reproductive behaviors and risk of developing breast cancer according to tumor subtype: A systematic review and meta-analysis of epidemiological studies.

Auteurs : Lambertini M, Santoro L, Del Mastro L, Nguyen B, Livraghi L, Ugolini D, Peccatori FA, Azim HA Jr
Jaar : 2016
Journal : Cancer Treat Rev
Volume : 49
Pagina's : 65-76

Is it possible to improve communication around radiotherapy delivery: A randomized study to assess the efficacy of team training?

Auteurs : Liénard A, Delevallez F, Razavi D, Gibon AS, Libert Y, Delvaux N, Marchal S, Etienne AM, Bragard I, Reynaert C, Slachmuylder JL, Durieux JF, Farvacques C, Scalliet P, Van Houtte P, Coucke P, Merckaert I
Jaar : 2016
Journal : Radiother Oncol
Volume : 119
Pagina's : 361-67

Eribulin in the soft tissue sarcoma therapeutic landscape: little is good, then more is better

Auteurs : Awada A, Penel N, Kotecki N
Jaar : 2016
Journal : TCR
Volume : 5(6)
Pagina's : s1160-62

Threat posed by unproven drugs in medical oncology.

Auteurs : Pondé N, Ades F, de Azambuja E
Jaar : 2016
Journal : ESMO Open
Volume : 1
Pagina's : e000064

Predictors of physicians' satisfaction with their management of uncertainty during a decision-making encounter with a simulated advanced stage cancer patient.

Auteurs : Libert Y, Canivet D, Ménard C, Van Achte L, Farvacques C, Merckaert I, Liénard A, Klastersky J, Reynaert C, Slachmuylder JL, Durieux JF, Delvaux N, Razavi D
Jaar : 2016
Journal : Patient Educ Couns
Volume : 99(7)
Pagina's : 1121-9

Lower urinary tract dysfunction following nerve sparing radical hysterectomy: A systematic review.

Auteurs : Aoun F, Albisinni S, Peltier A, Maoula A, Van Velthoven R, Roumeguère T
Jaar : 2016
Journal : Prog Urol
Volume : 26(1)
Pagina's : 1-9

Sentinel Lymph Node Detection by Blue Dye Versus Indocyanine Green Fluorescence Imaging in Colon Cancer.

Auteurs : Liberale G, Vankerckhove S, Gomez Galdon M, Larsimont D, Ahmed B, Bouazza F, Moreau M, El Nakadi I, Donckier V, Bourgeois P
Jaar : 2016
Journal : Anticancer Res
Volume : 36
Pagina's : 4853-8

Will Testicular Germ Cell Tumors Remain Untargetable?

Auteurs : Aoun F, Kourie HR, Albisinni S, Roumeguère T
Jaar : 2016
Journal : Target Oncol
Volume : 11(6)
Pagina's : 711-21

Identification of early breast cancer patient cohorts who may benefit from lapatinib therapy.

Auteurs : Strasser-Weippl K, Horick N, Smith IE, O Shaughnessy J, Ejlertsen B, Boyle F, Buzdar AU, Fumoleau P, Gradishar W, Martin M, Moy B, Piccart-Gebhart M, Pritchard KI, Lindquist D, Rappold E, Finkelstein DM, Goss PE
Jaar : 2016
Journal : Eur J Cancer
Volume : 56
Pagina's : 85-92

Innovative approach to older patients with malignant hemopathies.

Auteurs : Bron D, Soubeyran P, Fulop T
Jaar : 2016
Journal : Haematologica
Volume : 101
Pagina's : 893-5